weight loss
Showing all 4 results
-
Oxford Biologics
Retatrutide
Retatrutide is a novel therapeutic agent currently under investigation for its potential efficacy in the treatment of metabolic disorders. Early clinical trials suggest that it may significantly impact weight management and glucose regulation in affected populations. As research progresses, comprehensive evaluation of its safety and effectiveness will be paramount to determining its role in clinical practice. The ongoing studies aim to elucidate the full range of benefits and risks associated with this promising compound. Next-generation GLP-3 weight-loss peptide. May support up to 20-25% body-weight loss.
Price range: 20.000,00 EGP through 50.000,00 EGPIncludes reconstitution solution + syringes
Select size This product has multiple variants. The options may be chosen on the product page Quick order -
Oxford Biologics
Semaglutide
GLP-1 receptor agonist. Clinically proven 10-15% body-weight reduction.
6.000,00 EGPIncludes reconstitution solution + syringes
-
Oxford Biologics
Tirzepatide
Dual-action GLP-1 and GIP peptide. May support 15-22% body-weight loss.
Price range: 9.000,00 EGP through 22.000,00 EGPIncludes reconstitution solution + syringes
Select size This product has multiple variants. The options may be chosen on the product page Quick order
